DESIGN THERAPEUTICS INC. - COMMON STOCK
3,7300
11-февраля-25 16:45:00
15 мин. задержка
Акции
-0,5300
-12,44%
Сегодняшний диапазон
3,6900 - 4,1500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Design Therapeutics Highlights Upcoming Milestones and Reports Second Quarter 2022 Financial Results
08 авг 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference
03 авг 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the 2022 Jefferies Healthcare Conference
01 июн 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
09 май 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
30 мар 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
10 мар 2022 16:02:00 Источник Nasdaq GlobeNewswire
-
09 мар 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
28 фев 2022 16:05:00 Источник Nasdaq GlobeNewswire
-
Design Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
10 фев 2022 06:30:00 Источник Nasdaq GlobeNewswire
-
Design Therapeutics Appoints Drug Development Expert, Jae Kim, M.D., as Chief Medical Officer
01 фев 2022 16:05:01 Источник Nasdaq GlobeNewswire
-
Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
09 ноя 2021 16:05:01 Источник Nasdaq GlobeNewswire
-
08 сен 2021 06:30:00 Источник Nasdaq GlobeNewswire
-
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
09 авг 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
07 июн 2021 16:10:00 Источник Nasdaq GlobeNewswire
-
Design Therapeutics Expands Board of Directors with Key Appointments
07 июн 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
10 май 2021 16:05:00 Источник Nasdaq GlobeNewswire